 The Oncology Report | Slowed Infusions Cut Hypersensitivity Reactions in Rituximab Desensitization The Oncology Report ORLANDO – A slowed, rate-controlled infusion of rituximab during a desensitization protocol significantly reduced the number of hypersensitivity reactions compared with faster, standard-rate desensitization infusions. "The safety of rituximab ... |
